Expression of CD47 in bladder cancer

被引：0
|
作者：
Demirci, U. [1 ]
Bagriacik, E. U. [2 ]
Irkkan, C. [3 ]
Dede, D. S. [4 ]
Yaman, E. [2 ]
Altinova, S. [4 ]
Gulnur, G. [4 ]
Yalcin, B. [4 ]
机构：
[1] Dr Abdurrahman Yurtaslan Ankara Oncol Training &, Ankara, Turkey
[2] Gazi Univ, Fac Med, Ankara, Turkey
[3] Dr Abdurrahman Yurtaslan Oncol Training & Res Hos, Ankara, Turkey
[4] Ataturk Training & Res Hosp, Ankara, Turkey
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2807
引用
收藏
页码：S678 / S678
页数：1
相关论文
共 50 条
  • [31] MAPK REGULATES CD47 EXPRESSION IN MELANOMA CELLS
    Liu, Fen
    Tseng, Cindy Hsin-Yi
    Jin, Lei
    Zhang, Xu Dong
    Jiang, Chen Chen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 26 - 26
  • [32] Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer
    Huang, Xiting
    Wang, Qian
    Nan, Yanyang
    Zhang, Xuyao
    Xu, Ke
    Ju, Dianwen
    Ding, Weihong
    BIOMEDICINES, 2024, 12 (09)
  • [33] Checkpoint CD47 expression in classical Hodgkin lymphoma
    Gholiha, Alex Reza
    Hollander, Peter
    Lof, Liza
    Glimelius, Ingrid
    Hedstrom, Gustaf
    Molin, Daniel
    Hjalgrim, Henrik
    Smedby, Karin E.
    Hashemi, Jamileh
    Amini, Rose-Marie
    Enblad, Gunilla
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (05) : 580 - 589
  • [34] Clinicopathological significance of CD47 expression in hepatocellular carcinoma
    Kim, Hyunsung
    Bang, Seongsik
    Jee, Seungyun
    Paik, Seung Sam
    Jang, Kiseok
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (02) : 111 - 115
  • [35] Clinicopathological analysis of CD47 and signal regulatory protein alpha expression in myeloid sarcoma patients: CD47 expression is a favourable prognostic factor
    Tanaka, Ken
    Miyoshi, Hiroaki
    Kawamoto, Keisuke
    Shimasaki, Yasumasa
    Nakashima, Kazutaka
    Imamoto, Teppei
    Yamada, Kyohei
    Takeuchi, Mai
    Moritsubo, Mayuko
    Furuta, Takuya
    Kohno, Kei
    Tamura, Sinobu
    Sonoki, Takashi
    Ohshima, Koichi
    PATHOLOGY, 2024, 56 (01) : 81 - 91
  • [36] Blockade of CD47 or SIRPα: a new cancer immunotherapy
    Murata, Yoji
    Saito, Yasuyuki
    Kotani, Takenori
    Matozaki, Takashi
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (10) : 945 - 951
  • [37] Cancer immunotherapy targeting the CD47/SIRPα axis
    Weiskopf, Kipp
    EUROPEAN JOURNAL OF CANCER, 2017, 76 : 100 - 109
  • [38] CD47: Beyond an immune checkpoint in cancer treatment
    Bian, Hui-Ting
    Shen, Yi-Wen
    Zhou, Yu-Dong
    Nagle, Dale G.
    Guan, Ying-Yun
    Zhang, Wei-Dong
    Luan, Xin
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2022, 1877 (05):
  • [39] CD47 receptor as a primary target for cancer therapy
    Ratnikova, N. M.
    Lezhnin, Y. N.
    Frolova, E. I.
    Kravchenko, J. E.
    Chumakov, S. P.
    MOLECULAR BIOLOGY, 2017, 51 (02) : 216 - 225
  • [40] Role of CD47 in triple negative breast cancer
    Kaur, Sukhbir
    Singh, Satya
    Elkahloun, Abdel
    Wu, Weiwei
    Song, Tim
    Arora, Ashi
    Roberts, David
    FASEB JOURNAL, 2015, 29
12345